New drug aims to tame inflammation in kidney disease patients
Disease control
Completed
This study tested a drug called TOUR006 in 143 adults with chronic kidney disease and high levels of a blood marker for inflammation (hs-CRP). The goal was to see if monthly or quarterly injections could safely lower inflammation, which is linked to worse kidney outcomes. The stu…
Phase: PHASE2 • Sponsor: Tourmaline Bio, Inc. • Aim: Disease control
Last updated May 05, 2026 11:53 UTC